# A Phase 3 Clinical Trial of Intravenous Sodium Thiosulfate in Acute Calciphylaxis Patients

> **NCT03150420** · PHASE3 · TERMINATED · sponsor: **Hope Pharmaceuticals** · enrollment: 29 (actual)

## Conditions studied

- Calciphylaxis

## Interventions

- **DRUG:** Sodium Thiosulfate
- **DRUG:** Placebo-Normal Saline

## Key facts

- **NCT ID:** NCT03150420
- **Lead sponsor:** Hope Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-05-24
- **Primary completion:** 2020-04-15
- **Final completion:** 2020-04-15
- **Target enrollment:** 29 (ACTUAL)
- **Why stopped:** Inability to accrue subjects that met the exclusion criterion "Any prior (within the past 30 days) or current Sodium Thiosulfate treatment".
- **Last updated:** 2020-05-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03150420

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03150420, "A Phase 3 Clinical Trial of Intravenous Sodium Thiosulfate in Acute Calciphylaxis Patients". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03150420. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*